ATE193519T1 - Herstellung von allylbernsteinsäurederivaten und ausgangsprodukte dafür - Google Patents

Herstellung von allylbernsteinsäurederivaten und ausgangsprodukte dafür

Info

Publication number
ATE193519T1
ATE193519T1 AT96935008T AT96935008T ATE193519T1 AT E193519 T1 ATE193519 T1 AT E193519T1 AT 96935008 T AT96935008 T AT 96935008T AT 96935008 T AT96935008 T AT 96935008T AT E193519 T1 ATE193519 T1 AT E193519T1
Authority
AT
Austria
Prior art keywords
alkyl
pct
formula
date
production
Prior art date
Application number
AT96935008T
Other languages
English (en)
Inventor
Fionna M Martin
Christopher N Lewis
Stephen A Bowles
Richard S Todd
Original Assignee
British Biotech Pharm
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by British Biotech Pharm filed Critical British Biotech Pharm
Application granted granted Critical
Publication of ATE193519T1 publication Critical patent/ATE193519T1/de

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C67/00Preparation of carboxylic acid esters
    • C07C67/30Preparation of carboxylic acid esters by modifying the acid moiety of the ester, such modification not being an introduction of an ester group
    • C07C67/333Preparation of carboxylic acid esters by modifying the acid moiety of the ester, such modification not being an introduction of an ester group by isomerisation; by change of size of the carbon skeleton
    • C07C67/343Preparation of carboxylic acid esters by modifying the acid moiety of the ester, such modification not being an introduction of an ester group by isomerisation; by change of size of the carbon skeleton by increase in the number of carbon atoms
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02PCLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00Technologies relating to chemical industry
    • Y02P20/50Improvements relating to the production of bulk chemicals
    • Y02P20/55Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
AT96935008T 1995-11-16 1996-10-16 Herstellung von allylbernsteinsäurederivaten und ausgangsprodukte dafür ATE193519T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB9523493.6A GB9523493D0 (en) 1995-11-16 1995-11-16 Preparation of allyl succinate derivatives and starting materials therefore
PCT/GB1996/002531 WO1997018183A1 (en) 1995-11-16 1996-10-16 Preparation of allyl succinate derivatives and starting materials therefor

Publications (1)

Publication Number Publication Date
ATE193519T1 true ATE193519T1 (de) 2000-06-15

Family

ID=10784009

Family Applications (1)

Application Number Title Priority Date Filing Date
AT96935008T ATE193519T1 (de) 1995-11-16 1996-10-16 Herstellung von allylbernsteinsäurederivaten und ausgangsprodukte dafür

Country Status (8)

Country Link
US (1) US5936116A (de)
EP (1) EP0874799B1 (de)
JP (1) JP2000500152A (de)
AT (1) ATE193519T1 (de)
AU (1) AU7311396A (de)
DE (1) DE69608704T2 (de)
GB (2) GB9523493D0 (de)
WO (1) WO1997018183A1 (de)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6462023B1 (en) 1996-09-10 2002-10-08 British Biotech Pharmaceuticals, Ltd. Cytostatic agents
NZ333923A (en) 1996-09-10 2000-11-24 British Biotech Pharm Cytostatic hydroxamic acid derivatives for inhibiting proliferation of tumour cells
US6797820B2 (en) * 1999-12-17 2004-09-28 Vicuron Pharmaceuticals Inc. Succinate compounds, compositions and methods of use and preparation
ATE322266T1 (de) * 2000-05-15 2006-04-15 Celgene Corp Pharmazeutische zusammensetzungen zur behandlung von krebs welche thalidomid und topoisomerase inhibitoren enthalten
GB0419361D0 (en) * 2004-08-31 2004-10-06 Novartis Ag Organic compounds

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4939288A (en) * 1989-01-23 1990-07-03 Monsanto Company Method of preparing (R)-succinic acid derivatives
GB9416897D0 (en) * 1994-08-20 1994-10-12 British Biotech Pharm Metalloproteinase inhibitors

Also Published As

Publication number Publication date
DE69608704D1 (de) 2000-07-06
AU7311396A (en) 1997-06-05
WO1997018183A1 (en) 1997-05-22
GB2321458A (en) 1998-07-29
GB9523493D0 (en) 1996-01-17
JP2000500152A (ja) 2000-01-11
EP0874799A1 (de) 1998-11-04
GB9806347D0 (en) 1998-05-20
US5936116A (en) 1999-08-10
EP0874799B1 (de) 2000-05-31
DE69608704T2 (de) 2000-11-30

Similar Documents

Publication Publication Date Title
DE69711391D1 (de) Verbessertes verfahren zum herstellen von geschützten 3,4-dihydroxybuttersäure estern
MY145819A (en) Process and intermediates useful in the preparation of pharmaceutical compounds as fulvestrant
DE69615844D1 (de) Verfahren zur herstellung von 2-(6-substituiertes pyrid-2-yloxy methyl) phenylacetat
HU9501585D0 (en) Azoxycyanobenzene-derivatives, process for their preparation, fungicidal compositions containing them
DK1018511T3 (da) Isochromanforbindelser og fremgangsmåde til deres fremstilling
ATE148111T1 (de) Verfahren zur herstellung von taxanderivaten, die so erlangten neuen derivate und diese enthaltende zusammensetzungen
DE69608704D1 (de) Herstellung von allylbernsteinsäurederivaten und ausgangsprodukte dafür
DK0854873T3 (da) Galathanminderivater og fremgangsmåde til deres fremstilling
GEP20032928B (en) Halo Derivatives of 9-Deoxo-9a-Aza-9a-Homerythromycin A, Method for its Production, Pharmaceutical Compositions Containing the Same and Their Use for Treatment or Prevention of Bacterial Infections
RU94026277A (ru) Пиримидиниловые производные акриловой кислоты, способ их получения, способ подавления фитопатогенных грибов, фунгицидное средство
ATE159517T1 (de) Verfahren zur herstellung von n-carbonylarylimine als zwischenprodukte in der synthese von therapeutisch aktiven taxol-derivaten
AU2001225380A1 (en) 2-thio-4h-3,1-benzoxazin-4-one derivatives for use as enzyme inhibitors
DK0888288T3 (da) Carboxylsyreamider med fungicid virkning
AU703163B2 (en) Anti-ischaemic hydroxylamine derivatives and pharmaceutical compositions
Bongini et al. Synthesis of perhydroxazin-4-ones. Competitive Mukaiyama versus hetero Diels–Alder reaction in the cycloaddition of 2-aza-3-trimethylsilyloxy-1, 3-butadiene and aldehydes
RU95113420A (ru) Способы получения 1,3-оксазолидин-5-карбоновой кислоты
KR970705540A (ko) 구아니디노메틸 사이클로헥산 카복실산 에스테르 유도체(Guanidinomethyl cyclohexane carboxylic ester derivative)
ATE189886T1 (de) Synthese von carbonsäurederivaten
BR9707777A (pt) Derivados do ácido 1 (2h) quiloleína carboxílico seu processo preparo e sua aplicação a síntese de produtos dotados de propriedades antibióticas
ATE370121T1 (de) Kurze synthese von pharmazeutischen zwischenprodukten auf pyridinbasis mit schwefelhaltigen gruppen in der 2- und 3-stellung
RU94037966A (ru) Карбоксамидные соединения, способ получения карбоксамидных соединений, промежуточные соединения и способы их получения
AU2003293609A1 (en) Propargylether derivatives, a process for their preparation and their use for controlling phytopathogenic microorganisms
AU2001239227A1 (en) Method for producing n-alkoxy-n-alkylamides
TW341560B (en) N-sulfonyl and N-sulfinyl amino acid derivatives as fungicides compounds of formula I can be used in plant protection in the form of suitable compositions, for example in the control of fungal diseases.
HK1018456A1 (en) Process for the preparation of n-[2-(dimethylamino)ethyl]acridine-4-carboxamide used as anti cancer compounds

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties